War wound treatment complications due to transfer of an IncN plasmid harboring blaOXA-181 from Morganella morganii to CTX-M-27-producing sequence type 131 Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 6, 2015, Pages 3556-3562

  McGann, Patrick ^a   Snesrud, Erik ^a   Ong, Ana C ^a   Appalla, Lakshmi ^a   Koren, Michael ^b   Kwak, Yoon I ^a   Waterman, Paige E ^a,c   Lesho, Emil P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c Global Emerging Infections Surveillance and Response System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIN; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE;

ABDOMINAL PAIN; ABSCESS; ABSCESS DRAINAGE; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACKACHE; BACTERIAL VIRULENCE; BATTLE INJURY; BLAST INJURY; CASE REPORT; CHILL; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; LAMINECTOMY; LAPAROTOMY; MALE; MORGANELLA MORGANII; NEPHROTOXICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT FEVER; RECURRENT INFECTION; WOUND INFECTION; YOUNG ADULT; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; PLASMID; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORINS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; IMIPENEM; MICROBIAL SENSITIVITY TESTS; MORGANELLA MORGANII; PLASMIDS;

EID: 84959929614     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04442-14     Document Type: Article

References (42)

1. Schoenfeld AJ, Dunn JC, Bader JO, Belmont PJ, Jr. 2013. The nature and extent of war injuries sustained by combat specialty personnel killed and wounded in Afghanistan and Iraq, 2003-2011. J Trauma Acute Care Surg 75:287-291. http://dx.doi.org/10.1097/TA.0b013e31829a0970.
2. Dismounted Complex Blast Injury Task Force. 2011. Dismounted complex blast injury. http://armymedicine.mil/Documents/DCBI-Task-Force-Report-Redacted-Final.pdf. Last accessed December 2014.
3. Petersen K, Riddle MS, Danko JR, Blazes DL, Hayden R, Tasker SA, Dunne JR. 2007. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 245:803-811. http://dx.doi.org/10.1097/01.sla.0000251707.32332.c1.
4. Joint Trauma System. 2012. Joint theater trauma system clinical practice guideline: management of high bilateral amputations. http://usaisr.amedd.army.mil/cpgs/High-Bilateral-Amputations-7-Mar-12.pdf. Last accessed December 2014.
5. Forgione MA, Moores LE, Wortmann GW, Prevention of Combat-Related Infections Guidelines Panel. 2011. Prevention of infections associated with combat-related central nervous system injuries. J Trauma 71:S258-S263. http://dx.doi.org/10.1097/TA.0b013e318227ad86.
6. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12. http://dx.doi.org/10.1086/595011.
7. Owens CD, Stoessel K. 2008. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 70(Suppl 2):S3-S10. http://dx.doi.org/10.1016/S0195-6701(08)60017-1.
8. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449-456. http://dx.doi.org/10.1016/S1286-4579(03)00049-2.
9. Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 58:4997-5004. http://dx.doi.org/10.1128/AAC.02824-14.
10. Nicolas-Chanoine MH, Bertrand X, Madec JY. 2014. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543-574. http://dx.doi.org/10.1128/CMR.00125-13.
11. Oteo J, Perez-Vazquez M, Campos J. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 23:320-326. http://dx.doi.org/10.1097/QCO.0b013e3283398dc1.
12. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286-294. http://dx.doi.org/10.1086/653932.
13. Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. 2012. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother 67:2793-2803. http://dx.doi.org/10.1093/jac/dks301.
14. Patel G, Bonomo RA. 2011. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther 9:555-570. http://dx.doi.org/10.1586/eri.11.28.
15. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25: 682-707. http://dx.doi.org/10.1128/CMR.05035-11.
16. Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, Savard P, Humphries RM, Kallen AJ, Limbago BM. 2013. New Delhi metallo-beta-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis 19:870-878. http://dx.doi.org/10.3201/eid1906.121515.
17. Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. 2011. OXA-163, an OXA-48-related class D betalactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55:2546-2551. http://dx.doi.org/10.1128/AAC.00022-11.
18. Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 67:1597-1606. http://dx.doi.org/10.1093/jac/dks121.
19. Mathers AJ, Hazen KC, Carroll J, Yeh AJ, Cox HL, Bonomo RA, Sifri CD. 2013. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the New World. J Clin Microbiol 51:680-683. http://dx.doi.org/10.1128/JCM.02580-12.
20. OXA-181 carbapenemase gene from Citrobacter freundii. Antimicrob Agents Chemother 57:1965-1967. http://dx.doi.org/10.1128/AAC.01297-12.
21. Potron A, Nordmann P, Lafeuille E, Al Maskari Z, Al Rashdi F, Poirel L. 2011. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4896-4899. http://dx.doi.org/10.1128/AAC.00481-11.
22. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. 2001. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamaseproducing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7:88-91. http://dx.doi.org/10.1046/j.1469-0691.2001.00204.x.
23. Dortet L, Brechard L, Poirel L, Nordmann P. 2014. Impact of the isolation medium for detection of carbapenemase-producing Enterobacteriaceae using an updated version of the Carba NP test. J Med Microbiol 63:772-776. http://dx.doi.org/10.1099/jmm.0.071340-0.
24. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing. M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
25. Tijet N, Boyd D, Patel SN, Mulvey MR, Melano RG. 2013. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4578-4580. http://dx.doi.org/10.1128/AAC.00878-13.
26. Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15-22. http://dx.doi.org/10.1128/AAC.48.1.15-22.2004.
27. McGann P, Courvalin P, Snesrud E, Clifford RJ, Yoon EJ, Onmus-Leone F, Ong AC, Kwak YI, Grillot-Courvalin C, Lesho E, Waterman PE. 2014. Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure. mBio 5(2): e00915. http://dx.doi.org/10.1128/mBio.00915-14.
28. Clifford RJ, Milillo M, Prestwood J, Quintero R, Zurawski DV, Kwak YI, Waterman PE, Lesho EP, McGann P. 2012. Detection of bacterial 16S rRNA and identification of four clinically important bacteria by real-time PCR. PLoS One 7:e48558. http://dx.doi.org/10.1371/journal.pone.0048558.
29. Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, Buxton S, Cooper A, Markowitz S, Duran C, Thierer T, Ashton B, Meintjes P, Drummond A. 2012. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28:1647-1649. http://dx.doi.org/10.1093/bioinformatics/bts199.
30. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. http://dx.doi.org/10.1093/jac/dks261.
31. Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. 2006. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res 34:D32-D36. http://dx.doi.org/10.1093/nar/gkj014.
32. Salamov VSA. 2011. Automatic annotation of microbial genomes and metagenomic sequences, p 61-78. In Li RW (ed), Metagenomics and its applications in agriculture, biomedicine and environmental studies. Nova Science Publishers, Hauppauge, NY.
33. Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009-1010. http://dx.doi.org/10.1093/bioinformatics/btr039.
34. Zhao F, Bai J, Wu J, Liu J, Zhou M, Xia S, Wang S, Yao X, Yi H, Lin M, Gao S, Zhou T, Xu Z, Niu Y, Bao Q. 2010. Sequencing and genetic variation of multidrug resistance plasmids in Klebsiella pneumoniae. PLoS One 5:e10141. http://dx.doi.org/10.1371/journal.pone.0010141.
35. Sabate M, Navarro F, Miro E, Campoy S, Mirelis B, Barbe J, Prats G. 2002. Novel complex sul1-type integron in Escherichia coli carrying bla(CTX-M-9). Antimicrob Agents Chemother 46:2656-2661. http://dx.doi.org/10.1128/AAC.46.8.2656-2661.2002.
36. Waterman P, Kwak Y, Clifford R, Julius M, Onmus-Leone F, Tsurgeon C, Riley M, Black C, McGann P, Lesho E. 2012. A multidrug-resistance surveillance network: 1 year on. Lancet Infect Dis 12:587-588. http://dx.doi.org/10.1016/S1473-3099(12)70149-4.
37. Potron A, Poirel L, Nordmann P. 2011. Origin of OXA-181, an emerging carbapenem-hydrolyzing oxacillinase, as a chromosomal gene in Shewanella xiamenensis. Antimicrob Agents Chemother 55:4405-4407. http://dx.doi.org/10.1128/AAC.00681-11.
38. Dortet L, Poirel L, Nordmann P. 2014. Further proofs of concept for the Carba NP test. Antimicrob Agents Chemother 58:1269. http://dx.doi.org/10.1128/AAC.01825-13.
39. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. 2011. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 55: 1274-1278. http://dx.doi.org/10.1128/AAC.01497-10.
40. Carattoli A. 2013. Plasmids and the spread of resistance. Int J Med Microbiol 303:298-304. http://dx.doi.org/10.1016/j.ijmm.2013.02.001.
41. Potron A, Rondinaud E, Poirel L, Belmonte O, Boyer S, Camiade S, Nordmann P. 2013. Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D beta-lactamase from Enterobacteriaceae. Int J Antimicrob Agents 41:325-329. http://dx.doi.org/10.1016/j.ijantimicag.2012.11.007.
42. Stock I, Wiedemann B. 1998. Identification and natural antibiotic susceptibility of Morganella morganii. Diagn Microbiol Infect Dis 30:153-165. http://dx.doi.org/10.1016/S0732-8893(97)00243-5.